Evidence map›Paper›PMID 40895398›Full record

ArticleSAGE open medical case reports2025

Evaluating the risk factors for Lubinus SP II femoral stem fractures: A case series of 5 primary total hip arthroplasty patients with a mean follow-up of 7.5 years.

Alexis Panzures, Saim Faisel, Akkhash Sivakumar, Syed Ashoor Hasan Kazmi, Gareth Turnbull, Andy Ballantyne, Muhammad Adeel Akhtar

Abstract readCase Reports
In one paragraph

Article in SAGE open medical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Alexis PanzuresUniversity of Edinburgh, Edinburgh, UK.ORCID https://orcid.org/0009-0004-2364-4391
Saim FaiselAkhtar Saeed Medical and Dental College, Lahore, Pakistan.
Akkhash SivakumarUniversity of Edinburgh, Edinburgh, UK.ORCID https://orcid.org/0009-0009-9897-7445
Syed Ashoor Hasan KazmiVictoria Hospital, Kirkcaldy-NHS Fife, Scotland, UK.
Gareth TurnbullVictoria Hospital, Kirkcaldy-NHS Fife, Scotland, UK.
Andy BallantyneVictoria Hospital, Kirkcaldy-NHS Fife, Scotland, UK.
Muhammad Adeel AkhtarUniversity of Edinburgh, Edinburgh, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The reported rate of femoral stem fracture after total hip arthroplasty (THA) varies between less than 0.1 and 3.4%. The study aimed to evaluate the incidence of Lubinus SP II femoral stem fracture in our population and associated risk factors, and to examine clinical outcomes following revision THA for SP II stem fracture. 4244 primary THAs incorporating the anatomic femoral stem were identified within our institution from a prospectively compiled arthroplasty patient database. 5 patients presented with a broken Lubinus SP II anatomical hip stem. Immediately postoperatively, the operating consultant submitted intraoperative data detailing surgical approach, head size, and components used. Patients were reviewed 6 weeks postoperatively in an orthopedic clinic, then followed up at a dedicated orthopedic audit clinic at 6 months, 1, 3, and 5 years postoperatively, and data were collected prospectively. Postoperative complications were recorded at each follow-up visit. The incidence of stem fracture was 0.1% (5/4240) at a mean follow-up of 7.5 years. 3 were male, and 2 were female. The mean age was 63.8 years (range, 53-72, SD = 7.4). The mean weight was 109 kg (range, 88-128; SD = 14.2). The mean BMI was 36.5 kg m

Indexed as

case seriesfemoral stem fracturerevision arthroplastyTHAtotal hip arthroplasty

Identifiers

PMID40895398
PMCPMC12394862

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.